Generating page for printing...
Transforming the understanding
and treatment of mental illnesses.
NIMH envisions a world in which mental illnesses are prevented and cured.
Dr. Alyce S. Adams, PhD, presents “When Access isn’t Enough - Persistent Disparities among our Nation’s Insured” as part of the NIMH Director’s Innovation Speaker Series.
Clinical Research Studies (Clinical Trials) are of primary importance to the NIMH mission.
Dr. Yao's current research interests include method development for analyzing next generation sequencing data and for data dimension reduction.
Dr. Young received his B.A., M.D. and Ph.D from The Johns Hopkins University. The latter degree, obtained under the guidance of Michael Kuhar, described the development of in vitro receptor autoradiography and the first applications of the technique to the localization of neurotranmsitter receptors in human and other animal brains.
Carlos A. Zarate, M.D. is Chief, Section on the Neurobiology and Treatment of Mood Disorders and Chief of Experimental Therapeutics and Pathophysiology Branch (ETPB) at the National Institute of Mental Health, and Clinical Professor of Psychiatry and Behavioral Sciences, at The George Washington University.
Explore NIMH publications and online resources.
Explore las publicaciones y recursos en línea del NIMH.
Funding News for Current and Future NIMH Awardees.
Come join us! Researchers are invited to join the newly created RDoC forum.
Learn more about the NIH NeuroBioBank and brain tissue donation.
